Pharmaceutical major Wockhardt Ltd has agreed to sell its nutrition business to French food multinational Danone for about $356 million (Rs 1,576 crore), more than double the amount at which it had signed a similar deal with US pharmaceutical giant Abbott a year ago. The Abbott deal was called off after Wockhardt’s lenders opposed the sale of its nutrition business.
Under the current agreement, Danone will acquire Wockhardt's nutrition business and brands such as Farex, Dexolac, Nusobee and Protinex as well as related industrial operations from Carol Info Service, located in Punjab, to enter the baby nutrition and medical nutrition markets in India. Danone has global leadership in fresh dairy products and is the second largest player in bottled water and baby nutrition.
The renewal of negotiations became possible after the Bombay High Court refused to give an injunction to stall the sale of Wockhardt’s nutrition business as demanded by a section of the company's investors holding 40 per cent of its foreign currency convertible bonds last year. Wockhardt is yet to resolve its issues with its lenders, which include a clutch of investment firms and the company’s local competitor Sun Pharmaceuticals. The company may have to seek the Bombay High Court’s approval for the successful closure of the deal.crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: